Joao Andrade, CEO of WideCells Group plc speaks to us about today's corporate update
Joao Andrade, CEO of main market listed WideCells Group Plc, talks to us about their RNS update today highlighting board changes and the addition of a new institutional broker partner in WG Partners.
He also goes on to discuss why they have created a new Scientific Advisory Board made up of top medics from around the world.
Joao Andrade, CEO of WideCells Group plc speaks to us about today's corporate update
Joao Andrade, CEO of main market listed WideCells Group Plc, talks to us about their RNS update today highlighting board changes and the addition of a new institutional broker partner in WG Partners.
He also goes on to discuss why they have created a new Scientific Advisory Board made up of top medics from around the world.